Welcome to Nordic Society of Gynaecological Oncology

Menu

ENGOT-EN3-NSGO/PALEO

Study documentation (link to documents, only accessible with password to www.nsgo.org). Click HERE for access.  

 

Study sponsor

NSGO-CTU

NSGO Project Manager

Joan Løhndorf

NSGO-CTU, Rigshospitalet, Copenhagen, Denmark.

joan.loehndorf@regionh.dk

+45 3545 3398

Study chair

Mansoor Mirza
NSGO-CTU, Rigshospitalet, Copenhagen, Denmark.

mansoor.raza.mirza@regionh.dk

+45 3545 9624

Drug

Palbociclib/Placebo

Phase

II

Randomized trial

Yes 

Type

Randomized, double-blind, placebo-controlled, phase II trial

Total number of patients

78 

Number of patients recruited

Recruitment statistics – link

Trial status

Recruitment ended December 2018

Date of first site activated

15.02.2017

eCRF

Open Clinica test – link (protected information – access only with login)

Open Clinica Live – link (protected information – access only with login)

Site list

Site list – link (protected information – access only with login)

Protocol summary

ClinicalTrials.gov – link